Company: ZCARW
Filing Date: 2025-05-21
Form Type: SCHEDULE 13D
Source: 0001213900-25-046279
Chunk: 0

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-05-21
Form: SCHEDULE 13D
Chunk 0
---
November Transaction"), between the company and certain investors with Aegis Capital Corp. ("Aegis") as the placement agent, Mr. Eide purchased for an aggregate purchase price of $400,000.24, 93,458 shares of common stock, Series A warrants to purchase up to 934,580 shares of common stock and Series B warrants to purchase up to 402,821 shares of common stock. In the same transaction, Aegis, as placement agent was issued as compensation common warrants to purchase 213,785 shares of common stock, Series A warrants to purchase up to 2,137,850 shares of common stock and Series B warrants to purchase up to 921,452 shares of common stock. Mr. Eide is the Chief Executive Officer of Aegis Capital Corp. and has sole voting and investment power over the shares owned by Aegis Capital Corp.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 Pursuant to a securities purchase agreement dated December 23, 2024 (the "December Transaction"), between the company and certain investors with Aegis Capital Corp. as the placement agent, the Company issued as compensation to Aegis, as placement agent in three closings (i) common warrants to purchase 351, 593 shares of common stock, Series A warrants to purchase up to 5,425,280 shares of common stock and Series A warrants to purchase up to 1,406,370 shares of common stock in a December 24, 2024 closing; (ii) common warrants to purchase 192,180 shares of common stock, Series A warrants to purchase up to 3,002,808  shares of common stock and Series A warrants to purchase up to 768,719 shares of common stock in a February 4, 2025 closing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 Effective as of March 31, 2025 (the "March Settlement"), the Company entered into a settlement agreement to resolve certain claim with Aegis Capital Corp and certain affiliated in consideration for the issuance of $7,000,000 of securities of the Company in a private placement consisting of the issuance of (i) 32,000 shares of common stock, Series A Warrants to purchase up to 500,000 shares of common stock and Series B Warrants to purchase up to 128,000 shares of common stock to the Mr. Eide, (ii) 32,000 shares of common stock, Series A Warrants to purchase up to 500,000 shares of common stock